DE69233271D1 - Therapeutischer- und präventivimpfstoff gegen hiv - Google Patents
Therapeutischer- und präventivimpfstoff gegen hivInfo
- Publication number
- DE69233271D1 DE69233271D1 DE69233271T DE69233271T DE69233271D1 DE 69233271 D1 DE69233271 D1 DE 69233271D1 DE 69233271 T DE69233271 T DE 69233271T DE 69233271 T DE69233271 T DE 69233271T DE 69233271 D1 DE69233271 D1 DE 69233271D1
- Authority
- DE
- Germany
- Prior art keywords
- hiv
- conjugates
- therapeutic
- vaccine against
- against hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 230000003449 preventive effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 230000005540 biological transmission Effects 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 238000002965 ELISA Methods 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 abstract 1
- 229940033663 thimerosal Drugs 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68162491A | 1991-04-02 | 1991-04-02 | |
| US681624 | 1991-04-02 | ||
| US83778192A | 1992-02-14 | 1992-02-14 | |
| US837781 | 1992-02-14 | ||
| PCT/EP1992/000735 WO1992017590A1 (en) | 1991-04-02 | 1992-04-02 | Therapeutic and preventive vaccines for hiv |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69233271D1 true DE69233271D1 (de) | 2004-01-29 |
| DE69233271T2 DE69233271T2 (de) | 2004-09-09 |
Family
ID=27102688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69233271T Expired - Fee Related DE69233271T2 (de) | 1991-04-02 | 1992-04-02 | Therapeutischer- und präventivimpfstoff gegen hiv |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0536352B1 (de) |
| JP (1) | JPH05508165A (de) |
| AT (1) | ATE256745T1 (de) |
| AU (1) | AU1532392A (de) |
| CA (1) | CA2083949A1 (de) |
| DE (1) | DE69233271T2 (de) |
| WO (1) | WO1992017590A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6139843A (en) * | 1991-04-02 | 2000-10-31 | Albert Einstein College Of Medicine Of Yeshiva University | Peptide compositions for the treatment of HIV |
| IL110929A0 (en) * | 1993-09-13 | 1994-11-28 | Armel Sa | Multiple branch peptide constructions and pharmaceutical compositions containing them |
| GB9318901D0 (en) * | 1993-09-13 | 1993-10-27 | Centre Nat Rech Scient | Multiple branch peptide construction |
| US6838553B1 (en) * | 1999-10-05 | 2005-01-04 | Academia Sinica | Peptide repeat immunogens |
| US8915965B2 (en) | 2009-05-07 | 2014-12-23 | Depuy (Ireland) | Anterior stabilized knee implant |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU640619B2 (en) * | 1988-10-03 | 1993-09-02 | Repligen Corporation | Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
| IL94558A0 (en) * | 1989-06-06 | 1991-03-10 | Merck & Co Inc | Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it |
| JPH03271233A (ja) * | 1990-03-19 | 1991-12-03 | Inst Pasteur | ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発 |
| US6139843A (en) * | 1991-04-02 | 2000-10-31 | Albert Einstein College Of Medicine Of Yeshiva University | Peptide compositions for the treatment of HIV |
-
1992
- 1992-04-02 WO PCT/EP1992/000735 patent/WO1992017590A1/en active IP Right Grant
- 1992-04-02 AT AT92907420T patent/ATE256745T1/de not_active IP Right Cessation
- 1992-04-02 DE DE69233271T patent/DE69233271T2/de not_active Expired - Fee Related
- 1992-04-02 JP JP92507125A patent/JPH05508165A/ja active Pending
- 1992-04-02 CA CA002083949A patent/CA2083949A1/en not_active Abandoned
- 1992-04-02 EP EP92907420A patent/EP0536352B1/de not_active Expired - Lifetime
- 1992-04-02 AU AU15323/92A patent/AU1532392A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992017590A1 (en) | 1992-10-15 |
| ATE256745T1 (de) | 2004-01-15 |
| JPH05508165A (ja) | 1993-11-18 |
| CA2083949A1 (en) | 1992-10-03 |
| EP0536352A1 (de) | 1993-04-14 |
| DE69233271T2 (de) | 2004-09-09 |
| AU1532392A (en) | 1992-11-02 |
| EP0536352B1 (de) | 2003-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2002002592A0 (en) | Vaccine for the prophylactic or therapeutic immunization against HIV. | |
| WO2002096937A3 (en) | Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases | |
| WO2001039796A3 (en) | Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases | |
| RU95105991A (ru) | Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации | |
| WO2002020554A3 (en) | Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines | |
| IE903899A1 (en) | Vaccine composition with non-immunosuppressive T-cell¹epitope component | |
| Zhou et al. | Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice | |
| OA09802A (en) | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus. | |
| EP0491628A3 (de) | Lipopeptide, T-cytotoxische Lymphocyte aktivierend, und deren Verwendung als Vakzine | |
| ATE256745T1 (de) | Therapeutischer- und präventivimpfstoff gegen hiv | |
| LOLEIT et al. | Conjugates of synthetic lymphocyte-activating lipopeptides with segments from HIV proteins induce protein-specific antibody formation | |
| Que et al. | Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites | |
| SE9500418D0 (sv) | Novel attenuated pseudomonas aeruginosa strains | |
| WO2000008043A3 (en) | Prevention and treatment of viral disease | |
| IE904412A1 (en) | Malaria vaccine | |
| DE69626642T2 (de) | Cetp zur erhöhung des hdl-cholesterol-gehalts | |
| Peet et al. | Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV‐1 gp120 | |
| WO2005058968A1 (en) | A method to make a peptide-carrier conjugate with a high immunogenicity | |
| DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
| WO2003029285A3 (en) | Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections | |
| DK1146889T3 (da) | Identifikation af specifikke differentielt udtrykte mycobakterielle antigener og medicinsk anvendelse af Mycobakteriumproteinerne Rv0068 og Rv3407 | |
| Kaushik et al. | Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid | |
| ATE454394T1 (de) | Rekombinantes, 250 kda grosses antigen aus sporozoiten/merozoiten von eimeria maxima codierende nukleinsäuren und ihre verwendungen | |
| CN117440825A (zh) | 基于SARS-CoV-2病毒的受体结合结构域的疫苗组合物在保护性免疫的发展中的用途 | |
| JPH08198774A (ja) | Ｄｎａワクチン |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8339 | Ceased/non-payment of the annual fee |